News
1mon
IFLScience on MSNPill That Cures Ebola In Monkeys Ignites Hopes For A Human TreatmentM onkeys infected with the deadly Ebola virus have been successfully cured by a 10-day regimen of pills, leading scientists ...
Filoviruses are among the globe's most lethal—indeed, so dangerous they can be handled only in high-security laboratories.
The FDA has kicked off a six-month priority review of REGN-EB3, Regeneron’s three-drug therapy for Ebola virus infection, setting up a decision by 25 October. The timeline puts REGN-EB3 on track ...
Peter Loftus is a reporter for The Wall Street Journal in Philadelphia covering the pharmaceutical and medical-device ...
A team of scientists has uncovered the remarkable potential of a human antibody, mAb 3A6, in fighting Ebola virus infections.
The drug was administered to a handful of patients ... in Japan and is currently being investigated for use against Ebola virus disease, but the dosing regimen is uncertain.
This was the first time many had ever heard of the virus, but since it was first identified in 1976, there have actually been more than 20 serious Ebola incidents. Thankfully, none of them had the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results